METHODS: Consecutive AIS patients undergoing EVT for large vessel occlusion within 24 h from onset were analyzed. Receiver operating characteristic curves and multivariable logistic regression were investigated to evaluate the predictive performance of mCTA collateral score (range 0-5) and CCS (range 0-4) for good functional outcome (three-months modified Rankin Scale 0-2).
RESULTS: We included 201 subjects (59.7% females, mean age 75), of whom 96 (47.7%) had good outcome at three-months. Both CCS (OR = 14.4, 95% CI = 6.3-33.8) and mCTA (OR = 23.8, 95% CI = 10.1-56.4) collateral scores were independent predictors of outcome. The AUC of CCS was 0.80 (95% CI 0.73-0.86) and the best cut-off was ≥ 3 (87% sensitivity, 71% specificity), while the AUC of mCTA collateral score was 0.84 (95% CI 0.78-0.90) with an optimal cut-off of ≥ 4 (85% sensitivity, 87% specificity). Patients with good mCTA collaterals experienced smaller (16.6 vs. 63.7 mL, p < 0.001) infarct lesion as compared to those with mCTA poor collaterals.
CONCLUSIONS: mCTA discriminative ability for three-months 0-2 mRS was found to be comparable to CCS. mCTA appears a valid, non-invasive imaging modality for evaluating collaterals of AIS patients potentially eligible for EVT.
方法:对发病24h内接受EVT大血管闭塞的连续AIS患者进行分析。研究了受试者工作特征曲线和多变量逻辑回归,以评估mCTA侧支评分(范围0-5)和CCS(范围0-4)对良好功能结局(三个月改良的Rankin量表0-2)的预测性能。
结果:我们包括201名受试者(59.7%的女性,平均年龄75),其中96人(47.7%)在三个月时预后良好。CCS(OR=14.4,95%CI=6.3-33.8)和mCTA(OR=23.8,95%CI=10.1-56.4)侧支评分均为结局的独立预测因子。CCS的AUC为0.80(95%CI0.73-0.86),最佳截止值为≥3(87%灵敏度,71%的特异性),而mCTA侧支评分的AUC为0.84(95%CI0.78-0.90),最佳临界值≥4(85%敏感性,87%的特异性)。具有良好mCTA侧支的患者经历较小(16.6vs.63.7mL,p<0.001)与mCTA欠脉患者相比,梗死灶。
结论:发现3个月0-2mRS的mCTA判别能力与CCS相当。mCTA似乎是有效的,非侵入性成像模式,用于评估可能符合EVT的AIS患者的侧支。